Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Los Angeles CA, South Gate CA, San Dimas CA, Orange CA,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase 3, Recruiting
New
A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)
for
Neoplasms, Lung
Location: Los Angeles CA, Canton OH, Wilson NC
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07602855
Phase 1, Phase 2, Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
for
Colonic Neoplasms, Neoplasms, Colon
Location: Los Angeles CA, Tucson AZ, Grand Island NE, Omaha NE,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05855200
Phase 3, Recruiting
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Los Angeles CA, Fort Worth TX, Houston TX,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT07262619
Phase 1, Phase 2, Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for
Multiple Myeloma
Location: Los Angeles CA, Bullhead City AZ, Fort Worth TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05714839
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
for
Neoplasms, Lung
Location: Los Angeles CA, Canton OH, Toronto, Wilson NC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07099898
Phase 3, Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
for
Refractory Rheumatoid Arthritis (RA),
Location: Los Angeles CA, Covina CA, Los Alamitos CA,
Sponsor: Artiva Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06991114
Phase 2, Recruiting
Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)
for
Adolescent Drinking, Cannabis Use
Location: Commerce CA, North Hollywood CA, Pittsburgh PA
Sponsor: RAND
Sex: All
Age: 12 - 19
Code: NCT06699251
Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Location: Los Angeles CA, Orange CA, Loma Linda CA, San Diego CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT06368817
Phase 2, Recruiting
Pediatric Positive End Expiratory Pressure (PEEP) Titration Using Electrical Impedence Tomography (EIT)
for
Pediatric Acute Respiratory Distress Syndrome
Location: Los Angeles CA
Sponsor: Children's Hospital Los Angeles
Sex: All
Age: 0 - 18
Code: NCT06684119
Recruiting
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
for
B-cell Acute Lymphoblastic Leukemia, Obesity
Location: Los Angeles CA, Orange CA, San Francisco CA,
Sponsor: Etan Orgel
Sex: All
Age: 7 - 25
Code: NCT05082519
Phase 2, Recruiting
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
for
Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia,
Location: Los Angeles CA, Palo Alto CA, Salt Lake City UT,